Larimar Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.25

-0.02 (-0.47%)

As of Aug 15, 2:04 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +447.5% upside

Low Target $16.60

Average Target $23.27

High Target $30.48

Current Price $4.25

Current
$4.25

Target
$23.27

$16.60 $23.27 avg $30.48

Scenario Analysis

Bear Case

$16.60

290.6%

Low target

Base Case

$23.27

+447.5%

Avg target

Bull Case

$30.48

+617.2%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$6.42

-33.8% from high

52-Week Low

$2.72

+56.5% from low

Target vs 52W High

$23.27

+262.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%